Sign inJoin waitlistJoin the waitlist

PA

Paolo Abada

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled,…
The Lancet Oncology · 2019 · 1,406 citations
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised,…
The Lancet Oncology · 2015 · 700 citations
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Review · Liver International · 2019 · 487 citations

AZ
Andrew Zhu
17 papers
Richard Finn
10 papers
KP
Krish Patel
7 papers · 7 as a resident
CC
Catherine Coombs
6 papers · 1 as a fellow
Nirav Shah
6 papers
Shuo Ma
6 papers
DT
Donald Tsai
5 papers
Jennifer Woyach
5 papers
Joanna Rhodes
5 papers
RW
Richard Walgren
5 papers
SH
Stephen Howell
5 papers
Alvaro Alencar
4 papers